Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.103EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.485EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.119EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.276EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.111EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.515EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.287EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.170EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.506EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
N/AEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAKEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.596.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.473EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.357EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.118EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.309EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.632EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.108EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.332EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.42.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used